Neogen (NEOG) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2026, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Neogen Corporation  (NASDAQ: NEOG)
 

Neogen Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Neogen Corporation inventory turnover ratio, the Neogen Corporation's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 3.02 in the first quarter 2026, NEOG's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Neogen in Aug 31 2026 quarter, has decreased to 121 days, compare to 131 days, in the May 31 2026 quarter.

Within Healthcare sector 138 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 0 in the fourth quarter 2026, to 1385.

NEOG Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Neogen Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NEOG Inventory Turnover Ratio (Aug 31 2026)
I. Quarter		 (May 31 2026)
IV. Quarter		 (Feb 28 2026)
III. Quarter		 (Nov 30 2025)
II. Quarter		 (Aug 31 2025)
I. Quarter
Y / Y Inventory Growth -24.46 % -24.39 % -21.29 % -17.91 % -2.61 %
Y / Y Cost of Sales Growth 2.89 % -12.33 % 1.82 % 0.85 % 1.79 %
Inventory Turnover Ratio (TTM) 3.02 2.79 2.7 2.53 2.41
NEOG's Total Ranking # 1385 # 0 # 1218 # 36 # 47
Average inventory processing period 121 131 135 144 151
Seq. Inventory Growth 1.25 % -10.76 % -0.65 % -15.85 % 1.34 %
Seq. Cost of Sales Growth -0.15 % 4.89 % -5.08 % 3.51 % -14.93 %




Inventory Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 5
Healthcare Sector # 139
Overall Market # 1385

Inventory Turnover Ratio Statistics
High Average Low
3.39 2.65 1.89
(Aug 31 2023)   (May 31 2012)



NEOG Company Profile >> Back to NEOG Efficiency Comparisons >> Compare NEOG Inventory Turnover Ratio to its Competitors

Financial Statements
Neogen's Inventories $ 146 Millions Visit NEOG's Balance sheet
Neogen's Cost of Revenues TTM $ 465 Millions Visit NEOG's Income Statement
What are NEOG's Sales? Visit NEOG's Sales by Segment

Other Inventory Turnover Ratios
Neogen's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NEOG's Inventory Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NEOG's Competitors
Inventory Turnover Ratio for NEOG's Suppliers
Inventory Turnover Ratio for NEOG's Customers

You may also want to know
NEOG's Sales Growth Rates NEOG's Pe Price to earnings ratio NEOG's Receivables Turnover Ratio NEOG's Stock Quote
NEOG's Net Income Growth Rates NEOG's Ps Price to Sales ratio NEOG's Sales per Employee NEOG's Asset Turnover Ratio
NEOG's Net Margin NEOG's Pb Price to Book ratio NEOG's Financial Strength Ratios NEOG's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Aug 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Aug 31 2026 Inventories at quarter ending Aug 31 2026
Vanda Pharmaceuticals Inc   8.70 $ 14.704  Millions$ 2  Millions
Phathom Pharmaceuticals Inc   7.76 $ 53.106  Millions$ 7  Millions
Novavax inc   7.03 $ 90.533  Millions$ 13  Millions
Carlisle Companies Incorporated  6.99 $ 3,406.400  Millions$ 488  Millions
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Iovance Biotherapeutics inc   3.21 $ 177.232  Millions$ 55  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions

Date modified: 2026-10-08T04:22:54+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.